Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.
about
Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectivesAssociation of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.Getting at the Heart of Central Obesity and the Metabolic Syndrome.Beyond ejection fraction: an integrative approach for assessment of cardiac structure and function in heart failure.Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?Soluble Guanylate Cyclase Stimulators: a Novel Treatment Option for Heart Failure Associated with Cardiorenal Syndromes?Left ventricular strain and twisting in heart failure with preserved ejection fraction: an updated review.Heart Failure Stages Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction.Smoking and Cardiac Structure and Function in the Elderly: The ARIC Study (Atherosclerosis Risk in Communities).Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.Global Longitudinal Strain by Echocardiography Predicts Long-Term Risk of Cardiovascular Morbidity and Mortality in a Low-Risk General Population: The Copenhagen City Heart Study.Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis.Left ventricular long axis function assessed during cine-cardiovascular magnetic resonance is an independent predictor of adverse cardiac events.Left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: outcomes following an acute heart failure hospitalization.Importance of combined left atrial size and estimated pulmonary pressure for clinical outcome in patients presenting with heart failure with preserved ejection fraction.Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction.Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure.Reduced Myocardial Flow Reserve Is Associated With Diastolic Dysfunction and Decreased Left Atrial Strain in Patients With Normal Ejection Fraction and Epicardial Perfusion.Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial.The presence of diastolic and systolic dysfunction in patients with impaired relaxation filling pattern.New indices of left ventricular function: let's move from ejection fraction to more physiological parameters.Global longitudinal strain corrected by RR interval is a superior predictor of all-cause mortality in patients with systolic heart failure and atrial fibrillation.Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction.Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazine.Left ventricular deformation at rest predicts exercise-induced elevation in pulmonary artery wedge pressure in patients with unexplained dyspnoea.Utility of strain-echocardiography in current clinical practice.Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on HypertensioImpact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction.Left atrial changes in early stages of heart failure with preserved ejection fraction.Diastolic Dysfunction in Individuals With Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Antiretroviral Therapy (CHART) Study.Echo and heart failure: when do people need an echo, and when do they need natriuretic peptides?Prognostic implications of left ventricular strain by speckle-tracking echocardiography in population-based studies: a systematic review protocol of the published literatureComprehensive assessment of left ventricular myocardial function by two-dimensional speckle-tracking echocardiography
P2860
Q26741152-2C88C29D-8A70-44C6-B504-C450A2CCDBFBQ36463883-DD4DE719-8165-4ECB-84A2-A72D9BA6EC79Q36784075-B287C75E-84A8-44F4-AB7A-D230C34C0AA9Q37015771-4B0BE995-93F2-4200-B94C-272C2007258DQ38594949-25F2B192-6F54-481B-854C-65C886F25FFDQ38731482-4A282691-C515-4212-ACE3-1E7809572B99Q38818606-2475873F-5E17-4F06-8674-23D8082D2FF0Q38839006-0DCDA9CB-FEA6-4F4E-9394-C5341A810CD8Q39157911-1A51562E-EB60-463E-960F-3095215351FEQ39647469-B01E88B2-1A34-4256-ACC2-15C2D4C7DD90Q40071140-D5628B77-F2FD-4909-8111-8E17B3E31E64Q40256097-AE200A16-9877-4913-BFEE-8B860B580635Q40305859-35376DEC-66EA-41F8-B745-2849BD7A8B81Q42368579-AF6F3ACE-6B7B-484B-A581-9D457B752493Q42737666-6E531F5B-7D8D-4BD7-A49D-BFFE70CB6407Q47212510-7DEAF6E5-8727-4992-82F4-9623E772F11BQ47226767-13D5C2D6-3076-453D-ACE7-FD9C529845F4Q47369973-5B43F7E0-E0F4-47C9-8001-21624F804676Q47386435-1C4CBB2F-01CC-4648-83DD-FD91D0C44C2BQ47734069-B990B3A9-142D-4DE2-A485-81CCD078499EQ48310286-3CDED2F7-F833-4DAB-A25F-066459FF6E72Q48333794-80772B02-337A-4C95-B35D-63DDFBC67513Q48366489-82F510C5-C046-40A7-AB0A-0351048B2E3AQ48525059-FB2526D6-A007-446B-B4B7-5D5DFD850C79Q48565823-72FA700F-F3A0-4752-ABF6-4F1898A2AAA8Q48582664-C258095B-9D4C-4831-9446-8EE444565FFEQ48587170-60FFF304-FB46-44C5-A795-138C755D6B12Q48625724-227D5572-3A71-4C0B-A822-F45F63C2C6E2Q49607622-9FED2F78-B648-4D1A-97D8-9801CC62744CQ50099011-BA990785-55F0-4A6D-AFCE-1754E89B8697Q51751022-F8651F53-0A96-4BF3-B31B-00A2488A22CBQ52684874-56AE9491-FA33-4910-B5EA-20A7D9B0A4B8Q55346961-D282E3CB-8E57-44D7-BE7A-E26B6E38C7E2Q56517468-F903005A-A67D-4F84-882A-87310D38EB54Q58727756-F62C7641-39B8-41F6-A84B-A96E284A6BBC
P2860
Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic Importance of Impai ...... the Impact of Spironolactone.
@ast
Prognostic Importance of Impai ...... the Impact of Spironolactone.
@en
type
label
Prognostic Importance of Impai ...... the Impact of Spironolactone.
@ast
Prognostic Importance of Impai ...... the Impact of Spironolactone.
@en
prefLabel
Prognostic Importance of Impai ...... the Impact of Spironolactone.
@ast
Prognostic Importance of Impai ...... the Impact of Spironolactone.
@en
P2093
P2860
P1433
P1476
Prognostic Importance of Impai ...... the Impact of Spironolactone.
@en
P2093
Amil M Shah
Bertram Pitt
Brian Claggett
Marc A Pfeffer
Sanjiv J Shah
Scott D Solomon
P2860
P304
P356
10.1161/CIRCULATIONAHA.115.015884
P407
P577
2015-06-30T00:00:00Z